NR1H4 and cholestasis: The cholestasis induced by 17αE2 is a model for ICP.32 Administration of BAR502 in this model reduced biochemical makers of cholestasis (alkaline phospatase) and induced a pattern of expression of FXR target genes that is consistent with the activation of this nuclear receptor in the liver [24,29].